Aspire Private Capital’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.21M | Sell |
11,292
-1,975
| -15% | -$212K | 0.28% | 81 |
|
|
2025
Q1 | $1.34M | Buy |
13,267
+1,135
| +9% | +$114K | 0.33% | 63 |
|
|
2024
Q4 | $1.08M | Buy |
12,132
+319
| +3% | +$28.5K | 0.27% | 74 |
|
|
2024
Q3 | $990K | Buy |
11,813
+245
| +2% | +$20.5K | 0.24% | 75 |
|
|
2024
Q2 | $891K | Buy |
11,568
+2,687
| +30% | +$207K | 0.23% | 74 |
|
|
2024
Q1 | $608K | Buy |
8,881
+996
| +13% | +$68.2K | 0.16% | 103 |
|
|
2023
Q4 | $456K | Buy |
7,885
+773
| +11% | +$44.7K | 0.14% | 103 |
|
|
2023
Q3 | $376K | Sell |
7,112
-269
| -4% | -$14.2K | 0.12% | 102 |
|
|
2023
Q2 | $399K | Buy |
7,381
+188
| +3% | +$10.2K | 0.13% | 102 |
|
|
2023
Q1 | $360K | Buy |
+7,193
| New | +$360K | 0.12% | 105 |
|
|
2022
Q3 | – | Sell |
-53
| Closed | -$2K | – | 614 |
|
|
2022
Q2 | $2K | Hold |
53
| – | – | ﹤0.01% | 481 |
|
|
2022
Q1 | $2K | Hold |
53
| – | – | ﹤0.01% | 485 |
|
|
2021
Q4 | $2K | Hold |
53
| – | – | ﹤0.01% | 506 |
|
|
2021
Q3 | $2K | Hold |
53
| – | – | ﹤0.01% | 479 |
|
|
2021
Q2 | $2K | Sell |
53
-7
| -12% | -$264 | ﹤0.01% | 481 |
|
|
2021
Q1 | $2K | Sell |
60
-10
| -14% | -$333 | ﹤0.01% | 453 |
|
|
2020
Q4 | $3K | Hold |
70
| – | – | ﹤0.01% | 340 |
|
|
2020
Q3 | $3K | Buy |
+70
| New | +$3K | ﹤0.01% | 336 |
|
|
2020
Q1 | – | Sell |
-70
| Closed | -$3K | – | 265 |
|
|
2019
Q4 | $3K | Hold |
70
| – | – | ﹤0.01% | 338 |
|
|
2019
Q3 | $3K | Hold |
70
| – | – | ﹤0.01% | 314 |
|
|
2019
Q2 | $3K | Hold |
70
| – | – | ﹤0.01% | 350 |
|
|
2019
Q1 | $3K | Buy |
70
+10
| +17% | +$429 | ﹤0.01% | 393 |
|
|
2018
Q4 | $2K | Buy |
+60
| New | +$2K | ﹤0.01% | 400 |
|